Ganesh Benzoplast Ltd. to Review September Results on November 13

Ganesh Benzoplast Ltd. will consider its standalone and consolidated unaudited results for the quarter and half year ended September 30, 2026, at a board meeting on November 13, 2026, under SEBI Listing Regulations. The review comes as the company pursues a ₹1,154 crore sale of selected liquid-storage and rail assets and outlines expansion plans for chemicals and EPC operations.

When will Ganesh Benzoplast review its September 2026 results?

Ganesh Benzoplast will hold its board meeting on November 13, 2026, to consider and approve unaudited standalone and consolidated financial results for the quarter and half year ended September 30, 2026. The board will also consider the limited review reports associated with those results, according to the company’s disclosure under SEBI’s Listing Regulations.

The meeting is important because it will provide the next formal update on the company’s operating performance across its retained businesses. These include chemicals, engineering, procurement and construction, or EPC, activities, and a small stake in a Kandla terminal. The supplied corporate update indicates that the liquid-storage and rail operations are being monetised separately.

What assets are covered by the ₹1,154 crore transaction?

The transaction covers tank farms at JNPA, Goa and Cochin, along with the JNPA-linked rail business, for headline consideration of ₹1,154 crore. The corporate update also refers to a further amount linked to the exit valuation of investors, though it does not quantify that potential amount.

The update indicated that around ₹500 crore is expected before January 2027, around ₹300 crore before March 2027, and the remaining ₹354 crore in tranches over the following 12 to 18 months. The final tranche is linked to the transfer of a port licence and commissioning of tanks that remain under EPC execution. Ganesh Benzoplast said it would retain a small Kandla terminal stake, which it described as not material and excluded from the transaction’s non-compete arrangement.

Management cited cost inflation and the market outlook for tank farms as factors behind accepting the offer. The board’s consideration of the bid was described as a fiduciary matter for shareholders. The company also indicated that it does not plan to re-enter liquid storage in the near term under the non-compete arrangement with KKR.

How does Ganesh Benzoplast plan to use the sale proceeds?

Ganesh Benzoplast has indicated that the first ₹500 crore of receipts will be allocated among taxes and closure of existing bank limits, shareholder distributions, and expansion and EPC working capital. Around ₹190 crore to ₹200 crore is earmarked for tax and closure of current bank limits, around ₹200 crore for a buyback and special dividend, and around ₹100 crore for chemicals expansion and the EPC order book.

The update described the buyback and special dividend as committed from the first tranche, while use of later instalments will depend on capital requirements assessed by the board. It also said no large fresh debt is planned, apart from limits required for guarantees and margins. This makes the timing of deal receipts relevant to both balance-sheet management and capital deployment.

For investors, the September-quarter results will offer a financial baseline before the expected receipt schedule begins. The planned transaction could also change the mix of businesses contributing to future revenue and profit, with chemicals and EPC becoming the principal operating focus among the retained businesses.

What are the targets for chemicals and EPC operations?

Ganesh Benzoplast has outlined a target of about ₹60 crore to ₹70 crore in chemicals profit over four to five years, compared with chemical profit of ₹18 crore cited for the current year. For the June quarter, management cited chemicals turnover of about ₹60 crore and profit of ₹6 crore, while saying the existing capacity could exceed ₹20 crore of profit for the year if the run rate is sustained.

The company operates two chemical plants with capacity of about 1,000 tonnes a month each and reported utilisation of 70% to 80%. It plans to double only its REACH-certified plant, with completion targeted for July 2027. Export orders were stated to be above 600 tonnes, with annual exports expected to reach about 2,000 tonnes. Management also referred to discussions with licence and technology partners for niche agro and downstream derivatives.

In EPC, Ganesh Benzoplast cited an order of almost ₹300 crore from KKR and said its EPC order book for the year is about ₹500 crore, including that award. Management said the division, which earlier supported the tank-farm franchise, is now being operated as a standalone business. It referred to a combined ambition of about ₹210 crore in profit after tax from chemicals and EPC in three to five years, against a stated current base of about ₹70 crore.

What is the status of the insolvency case involving Ganesh Benzoplast?

The insolvency attempt against Ganesh Benzoplast has been dismissed through the appellate process, according to the supplied legal updates. Progfin Private Limited had sought to initiate a corporate insolvency resolution process over alleged credit-facility defaults by wholly owned subsidiary GBL Chemical Limited and an alleged corporate guarantee by Ganesh Benzoplast.

The Mumbai bench of the National Company Law Tribunal rejected the insolvency petition in September 2025. The National Company Law Appellate Tribunal dismissed Progfin’s appeal on June 30, 2026, and the company received the certified order on July 15. The supplied material also states that the Supreme Court dismissed a further appeal on August 18, 2026, with disclosure made on August 20.

The company said the appellate order carried no financial penalty. The dismissal removes the specific insolvency petition from the company’s disclosed legal matters, while the November 13 board meeting remains focused on the September financial statements and their limited review.

Conclusion

Ganesh Benzoplast’s November 13 meeting is set to bring together its latest reported financial performance and a wider shift in its operating structure. The ₹1,154 crore asset transaction, proposed shareholder distributions, chemicals expansion and EPC order execution are all relevant to how investors assess the company’s retained business profile.

Investors will watch for the September-quarter financial numbers, the limited review reports, and any board disclosure on the progress of the asset-sale receipts. The next stated operational milestone is completion of the expansion of the REACH-certified chemical plant, targeted for July 2027, while the first transaction receipt is expected before January 2027.